PERITONEAL DIALYSIS INTERNATIONAL, vol.25, no.4, pp.357-361, 2005 (SCI-Expanded)
Background. Atherosclerotic vascular diseases are the major cause of mortality in patients with end-stage renal disease (ESRD) treated with chronic peritoneal dialysis (CPD), even in children. Adiponectin (ADPN) is a recently discovered adipocyte-derived plasma protein having anti-atherogenic properties. ADPN levels are elevated in ESRD but-it has-been reported that ESRD patients with low plasma ADPN levels have a high risk of cardiovascular death.